57 identified a highly significant association between the presence of the EWS/FLI rearrangement and olaparib (Lynparza) sensitivity (geometric mean IC 50 for EWS/FLI = 4.7 versus 64 μM for non-EWS/FLI lines).
1
—
—
57 identified a highly significant association between the presence of the EWS/FLI rearrangement and olaparib (Lynparza) sensitivity (geometric mean IC 50 for EWS/FLI = 4.7 versus 64 μM for non-EWS/FLI lines).